FARICIMAB
faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe
FARICIMAB (14788H)
14788H
Body System:
Manner of administration:Injection
Restriction
Indication: Subfoveal choroidal neovascularisation (CNV)
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 2 | DPMQ: $934.41 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||